Faculty Bibliography
Searched for:
in-biosketch:true
person:tanejs01
Total Results:
831
Re: Ten-Year Mortality, Disease Progression, and Treatment-Related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received
PMID: 32073978
ISSN: 1527-3792
CID: 4312342
Re: Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
PMID: 31928459
ISSN: 1527-3792
CID: 4262902
Re: 18F-Fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in Patients with Early Biochemical Recurrence after Prostatectomy: A Prospective, Single-Centre, Single-Arm, Comparative Imaging Trial
PMID: 31928460
ISSN: 1527-3792
CID: 4262912
Re: Risk of Prostate Cancer for Men Fathering through Assisted Reproduction: Nationwide Population Based Register Study
PMID: 31928461
ISSN: 1527-3792
CID: 4262922
Multiparametric MRI for prostate cancer diagnosis: current status and future directions
The current diagnostic pathway for prostate cancer has resulted in overdiagnosis and consequent overtreatment as well as underdiagnosis and missed diagnoses in many men. Multiparametric MRI (mpMRI) of the prostate has been identified as a test that could mitigate these diagnostic errors. The performance of mpMRI can vary depending on the population being studied, the execution of the MRI itself, the experience of the radiologist, whether additional biomarkers are considered and whether mpMRI-targeted biopsy is carried out alone or in addition to systematic biopsy. A number of challenges to implementation remain, such as ensuring high-quality execution and reporting of mpMRI and ensuring that this diagnostic pathway is cost-effective. Nevertheless, emerging clinical trial data support the adoption of this technology as part of the standard of care for the diagnosis of prostate cancer.
PMID: 31316185
ISSN: 1759-4820
CID: 3977962
Re: Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de Novo Low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
PMID: 31829821
ISSN: 1527-3792
CID: 4234762
Re: Metastasis-Directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-Institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy
PMID: 31829824
ISSN: 1527-3792
CID: 4234782
Re: Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study
PMID: 31829822
ISSN: 1527-3792
CID: 4234772
Re: Diagnostic Accuracy of Multiparametric MRI versus 68Ga-PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in Patients with Prostate Cancer
PMID: 31710548
ISSN: 1527-3792
CID: 4185002
Re: Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium
PMID: 31710568
ISSN: 1527-3792
CID: 4185022
